Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Archives of Endocrinology and Metabolism
|
August 29, 2019
Pegvisomant for acromegaly: does it always works?
Sebastian J Neggers, Aart J van der Lely
Pituitary
|
August 29, 2016
Pregnancy and acromegaly
Ammar Muhammad, Sebastian J Neggers, Aart J van der Lely
Endocrine Development
|
May 9, 2013
Des-acyl ghrelin: a metabolically active peptide
Patric J Delhanty, Sebastian J Neggers, Aart J van der Lely
European Journal of Endocrinology
|
August 18, 2012
Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin
Patric J D Delhanty, Sebastian J Neggers, Aart J van der Lely
Frontiers of Hormone Research
|
April 16, 2014
Should we consider des-acyl ghrelin as a separate hormone and if so, what does it do?
Patric J D Delhanty, Sebastian J Neggers, Aart J van der Lely
European Journal of Endocrinology
|
November 4, 2010
Hypothesis: Extra-hepatic acromegaly: a new paradigm?
Sebastian J Neggers, John J Kopchick, Jens O L Jørgensen, et al.
European Journal of Endocrinology
|
April 3, 2020
Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly
Aart J van der Lely, Emmanuelle Kuhn, Ammar Muhammad, et al.
Journal of Pediatric Hematology/Oncology
|
February 27, 2010
The metabolic syndrome in adult survivors of childhood cancer, a review
Marjolein van Waas, Sebastian J Neggers, Aart-Jan van der Lelij, et al.
Diabetology & Metabolic Syndrome
|
July 23, 2021
Overweight and obesity in type 1 diabetes is not associated with higher ghrelin concentrations
Behiye Özcan, Patric J D Delhanty, Martin Huisman, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 16, 2013
Long-term nephrotoxicity in adult survivors of childhood cancer
Ilona A Dekkers, Karin Blijdorp, Karlien Cransberg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Archives of Endocrinology and Metabolism
|
August 29, 2019
Pegvisomant for acromegaly: does it always works?
Sebastian J Neggers, Aart J van der Lely
Pituitary
|
August 29, 2016
Pregnancy and acromegaly
Ammar Muhammad, Sebastian J Neggers, Aart J van der Lely
Endocrine Development
|
May 9, 2013
Des-acyl ghrelin: a metabolically active peptide
Patric J Delhanty, Sebastian J Neggers, Aart J van der Lely
European Journal of Endocrinology
|
August 18, 2012
Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin
Patric J D Delhanty, Sebastian J Neggers, Aart J van der Lely
Frontiers of Hormone Research
|
April 16, 2014
Should we consider des-acyl ghrelin as a separate hormone and if so, what does it do?
Patric J D Delhanty, Sebastian J Neggers, Aart J van der Lely
European Journal of Endocrinology
|
November 4, 2010
Hypothesis: Extra-hepatic acromegaly: a new paradigm?
Sebastian J Neggers, John J Kopchick, Jens O L Jørgensen, et al.
European Journal of Endocrinology
|
April 3, 2020
Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly
Aart J van der Lely, Emmanuelle Kuhn, Ammar Muhammad, et al.
Journal of Pediatric Hematology/Oncology
|
February 27, 2010
The metabolic syndrome in adult survivors of childhood cancer, a review
Marjolein van Waas, Sebastian J Neggers, Aart-Jan van der Lelij, et al.
Diabetology & Metabolic Syndrome
|
July 23, 2021
Overweight and obesity in type 1 diabetes is not associated with higher ghrelin concentrations
Behiye Özcan, Patric J D Delhanty, Martin Huisman, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 16, 2013
Long-term nephrotoxicity in adult survivors of childhood cancer
Ilona A Dekkers, Karin Blijdorp, Karlien Cransberg, et al.
Page
of 2